首页> 外文会议>IEEE International Ultrasonics Symposium >4D harmonic and subharmonic contrast-enhanced ultrasound for the characterization of breast masses: Update on a multi-center prospective study
【24h】

4D harmonic and subharmonic contrast-enhanced ultrasound for the characterization of breast masses: Update on a multi-center prospective study

机译:用于乳腺肿块表征的4D谐波和次谐波对比增强超声:一项多中心前瞻性研究的更新

获取原文

摘要

While mammography has high sensitivity in the detection of breast cancer, its low specificity results in a false-positive rate of roughly 80 %. Thus, a secondary tool for the characterization of breast masses would be highly beneficial. This ongoing study investigates the use of 4D harmonic and subharmonic imaging (HI and SHI) for the characterization of breast masses identified by mammography. Patients scheduled for an ultrasound guided biopsy of a mammographically-identified breast mass provided informed consent to undergo a contrast ultrasound study prior to biopsy. Scanning was performed using a modified Logiq 9 scanner with a 4D10L probe (GE Healthcare, Milwaukee, WI). Experimental software provided 4D HI (transmitting 2 cycle pulses at 5 MHz and receiving at 10 MHz) and 4D SHI (transmitting 4 cycle pulses at 5.8 MHz and receiving at 2.9 MHz). Subjects underwent 2D B-mode and power Doppler imaging (PDI), before receiving a 0.25 ml injection of the contrast agent Definity (Lantheus Medical Imaging, N. Billerica, MA) for 4D HI. After 30 minutes, subjects received a second injection of 20 µl/kg (up to 1.25 ml) for 4D SHI of the lesion. To date, 157 women have been enrolled and 149 have completed the study. Incomplete studies resulted from a failure to gain IV access (n=5), equipment malfunction (n=2), and a previously undisclosed contraindication to the contrast agent (n=1; unstable pulmonary status). 3D volume rates ranged from 1.7 Hz (for a 3.7×1.3×2.0 cm lesion) to 6.1 Hz (for a 6x4x6 mm lesion). SHI resulted in improved tissue suppression in 146 cases, equal tissue suppression in 2 cases, and inferior tissue suppression in 1 case relative to HI. Malignancy has been confirmed by pathology in 37 cases. Flow visualization (in all lesions) was evident in 82 cases on PDI, 8 cases on 4D HI, and 68 cases on 4D SHI. Thus, while the diagnostic value has yet to be determined by the radiologists, initial results indicate that 4D SHI provides impr- ved tissue suppression and visualization of flow in breast masses.
机译:乳房X线照相术对乳腺癌的检测具有很高的敏感性,但其低特异性导致假阳性率约为80%。因此,表征乳腺肿块的辅助工具将是非常有益的。这项正在进行的研究调查了4D谐波和次谐波成像(HI和SHI)在乳腺X线照相术中鉴定乳腺肿块的特征。计划进行乳房X线检查确定的乳腺肿块的超声引导穿刺活检的患者,在穿刺活检之前,已征得知情同意,接受造影剂超声检查。使用带有4D10L探头(GE Healthcare,Milwaukee,WI)的改良型Logiq 9扫描仪进行扫描。实验软件提供了4D HI(在5 MHz处发送2个周期脉冲并在10 MHz处接收)和4D SHI(在5.8 MHz处发送4个周期脉冲并在2.9 MHz处接收)。在接受0.25 ml的4D HI造影剂Definity(Lantheus Medical Imaging,N. Billerica,MA)注射之前,受试者先进行了2D B模式和功率多普勒成像(PDI)。 30分钟后,受试者接受第二次20 µl / kg(最大1.25 ml)的注射,用于病变的4D SHI。迄今为止,已有157名妇女参加,149名妇女完成了研究。不完整的研究是由于无法获得IV通路(n = 5),设备故障(n = 2)以及以前未公开的造影剂禁忌症(n = 1;不稳定的肺部状态)所致。 3D体积率的范围从1.7 Hz(对于3.7×1.3×2.0 cm病变)到6.1 Hz(对于6x4x6 mm病变)。相对于HI,SHI导致146例组织抑制得到改善,相等的组织抑制为2例,较劣的组织抑制为1例。 37例经病理证实为恶性肿瘤。在PDI上有82例,在4D HI上有8例,在4D SHI上有68例,血流显像(在所有病变中)均很明显。因此,尽管放射科医生尚未确定诊断价值,但初步结果表明4D SHI可提供改善的组织抑制作用并显示乳腺肿块中的血流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号